— Know what they know.
Not Investment Advice

NRXS AMEX

NeurAxis, Inc.
1W: -6.0% 1M: +19.5% 3M: -0.7% YTD: +59.4% 1Y: +128.6% 3Y: +74.7%
$7.11
-0.06 (-0.84%)
 
Weekly Expected Move ±13.7%
$5 $6 $7 $8 $9
AMEX · Healthcare · Biotechnology · Tech Score Strong Buy · Power 68 · $88.7M mcap · 9M float · 1.19% daily turnover · Short 51% of daily vol

Cash Flow Trends

Operating Cash Flow
-$6M -5.5% ▼
Capital Expenditures
$31K -12.1% ▼
5Y CAGR: +2.4%
Free Cash Flow
-$6M -5.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$1M -65.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$3M-$5M-$15M-$8M-$8M
Depreciation & Amort.$37K$37K$41K$38K$60K
Stock-Based Comp.$49K$27K$750K$1M$597K
Change in Working Capital$644K$1M-$666K$141K$0
Other Non-Cash Items$23K$1M$8M$560K$711K
Operating Cash Flow-$2M-$2M-$7M-$6M-$6M
— Investing Activities —
Capital Expenditures-$1K-$1K-$31K-$28K-$31K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0-$60K-$41K$0-$100K
Investing Cash Flow-$1K-$61K-$72K-$28K-$131K
— Financing Activities —
Net Debt Issuance$151K$3M$2M$5M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$510K-$867K-$323K-$168K$8M
Financing Cash Flow$661K$2M$7M$10M$8M
Net Change in Cash-$2M-$67K-$175K$4M$1M
Cash End of Period$321K$254K$79K$4M$5M
Free Cash Flow-$2M-$2M-$7M-$6M-$6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms